Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Bafna Pharmaceuticals had annual revenue of 1.55B INR with 6.52% growth. Bafna Pharmaceuticals had revenue of 440.01M in the quarter ending March 31, 2026, with 12.65% growth.

• Revenue: 1.55B
• Revenue Growth: +6.52%
• P/S Ratio: 2.11
• Revenue / Employee: 3.83M
• Employees: 406
• Market Cap: 3.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.55B	95.17M	6.52%
Mar 31, 2025	1.46B	-66.09M	-4.33%
Mar 31, 2024	1.52B	371.16M	32.18%
Mar 31, 2023	1.15B	302.10M	35.48%
Mar 31, 2022	851.40M	139.22M	19.55%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error